Picture 1 of 1
Donald L. Drakeman Lisa N. Drakeman Nekt From Breakthroug (Hardback) (UK IMPORT)
Another great item from Rarewaves | Free delivery!
Condition:
2 available
Shipping:
Located in: GU14 0GT, United Kingdom
Delivery:
Varies
Returns:
Payments:
Shop with confidence
Seller information
- 98.4% positive feedback
Registered as a Business Seller
Seller assumes all responsibility for this listing.
eBay item number:305352815024
Item specifics
- Condition
- Book Title
- From Breakthrough to Blockbuster : the Business of Biotechnology
- Publication Name
- From Breakthrough to Blockbuster
- Title
- From Breakthrough to Blockbuster
- Subtitle
- The Business of Biotechnology
- Format
- Hardcover
- ISBN-10
- 0195084004
- EAN
- 9780195084009
- ISBN
- 9780195084009
- Publisher
- Oxford University Press, Incorporated
- Genre
- Science, Business & Economics, Medical
- Topic
- Biotechnology, Entrepreneurship, Pharmacology, Economics / General
- Release Date
- 07/07/2022
- Release Year
- 2022
- Language
- English
- Country/Region of Manufacture
- US
- Item Height
- 1in
- Item Length
- 6in
- Item Width
- 9in
- Publication Year
- 2022
- Type
- Textbook
- Item Weight
- 17.6 Oz
- Number of Pages
- 240 Pages
About this product
Product Information
Financial Times Business Top Title March 2022How could a large collection of small companies, most with fewer than 50 employees, rise to compete with Big Pharma, one of the world's most breathtakingly expensive and highly regulated industries?Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.
Product Identifiers
Publisher
Oxford University Press, Incorporated
ISBN-10
0195084004
ISBN-13
9780195084009
eBay Product ID (ePID)
5057247712
Product Key Features
Book Title
From Breakthrough to Blockbuster : the Business of Biotechnology
Format
Hardcover
Language
English
Topic
Biotechnology, Entrepreneurship, Pharmacology, Economics / General
Publication Year
2022
Type
Textbook
Genre
Science, Business & Economics, Medical
Number of Pages
240 Pages
Dimensions
Item Length
6in
Item Height
1in
Item Width
9in
Item Weight
17.6 Oz
Additional Product Features
Lc Classification Number
Hd9999.B442d73 2022
Reviews
A fascinating guide to the complex business of biotechnology, with deep insights into the key factors, players, interactions and behaviors that have shaped the success of this industry. Suitable as a primer for those with no knowledge of the field, or as a refresher for the cognoscenti. Trigger warning: contains material that may distress pharma management, "Written with authority" -- Financial Times"A fascinating guide to the complex business of biotechnology, with deep insights into the key factors, players, interactions and behaviors that have shaped the success of this industry. Suitable as a primer for those with no knowledge of the field, or as a refresher for the cognoscenti. Trigger warning: contains material that may distress pharma management" -- Sir Gregory Winter FRS, Trinity College, Cambridge University, recipient of 2018 Nobel Prize in Chemistry"A must read for all biotechnology leaders, this is a state-of-the-art analysis of the industry from two of its most successful entrepreneurs and a top business school professor, bringing rigor and actionable insight." -- Dr Richard Mason, CEO of Apollo Therapeutics and former head of Johnson & Johnson's London Innovation Center"How is it possible that a few thousand small companies, many of them short-lived, can out-compete the mighty pharma majors at their own game? Understanding this puzzle is of fundamental importance for industry leaders and policy makers alike. This marvelous insider analysis is a must-read." -- Stefan Scholtes, Dennis Gillings Professor of Health Management, Cambridge University Centre for Health Leadership & Enterprise"A remarkable synthesis and analysis of the Biotech industry that is a must-read for those trying to develop new life-saving medicines." -- Margaret A. Liu, M.D., DSchc, MDhc, FISV, CEO of Pax Therapeutics, and board member, Ipsen, S.A."Anyone who wants to understand how to leverage ecosystems for innovation in the face of uncertainty must read this rigorous analysis of how biotech companies, investors, government and big pharma have worked together to achieve some of the biggest scientific and commercial breakthroughs of the last century." -- Arnoud De Meyer, Professor Emeritus and former President, Singapore Management University"A must read for everybody interested in the medical biotech industry, practically relevant and theoretically sound." -- J"urgen Mihm, , Professor of Technology and Operations Management at INSEAD"An outstanding overview of the science and the business of innovative drugs. Students, researchers and policy makers will be immensely benefited from this book." -- Mahmud Hassan, Ph.D, Professor and Director, Pharmaceutical Management Program, Rutgers Business School, "Written with authority" -- Financial Times "A fascinating guide to the complex business of biotechnology, with deep insights into the key factors, players, interactions and behaviors that have shaped the success of this industry. Suitable as a primer for those with no knowledge of the field, or as a refresher for the cognoscenti. Trigger warning: contains material that may distress pharma management" -- Sir Gregory Winter FRS, Trinity College, Cambridge University, recipient of 2018 Nobel Prize in Chemistry "A must read for all biotechnology leaders, this is a state-of-the-art analysis of the industry from two of its most successful entrepreneurs and a top business school professor, bringing rigor and actionable insight." -- Dr Richard Mason, CEO of Apollo Therapeutics and former head of Johnson & Johnson's London Innovation Center "How is it possible that a few thousand small companies, many of them short-lived, can out-compete the mighty pharma majors at their own game? Understanding this puzzle is of fundamental importance for industry leaders and policy makers alike. This marvelous insider analysis is a must-read." -- Stefan Scholtes, Dennis Gillings Professor of Health Management, Cambridge University Centre for Health Leadership & Enterprise "A remarkable synthesis and analysis of the Biotech industry that is a must-read for those trying to develop new life-saving medicines." -- Margaret A. Liu, M.D., DSchc, MDhc, FISV, CEO of Pax Therapeutics, and board member, Ipsen, S.A. "Anyone who wants to understand how to leverage ecosystems for innovation in the face of uncertainty must read this rigorous analysis of how biotech companies, investors, government and big pharma have worked together to achieve some of the biggest scientific and commercial breakthroughs of the last century." -- Arnoud De Meyer, Professor Emeritus and former President, Singapore Management University "A must read for everybody interested in the medical biotech industry, practically relevant and theoretically sound." -- Jürgen Mihm, , Professor of Technology and Operations Management at INSEAD "An outstanding overview of the science and the business of innovative drugs. Students, researchers and policy makers will be immensely benefited from this book." -- Mahmud Hassan, Ph.D, Professor and Director, Pharmaceutical Management Program, Rutgers Business School, "A fascinating guide to the complex business of biotechnology, with deep insights into the key factors, players, interactions and behaviors that have shaped the success of this industry. Suitable as a primer for those with no knowledge of the field, or as a refresher for the cognoscenti. Trigger warning: contains material that may distress pharma management" -- Sir Gregory Winter FRS, Trinity College, Cambridge University, recipient of 2018 Nobel Prize in Chemistry "A must read for all biotechnology leaders, this is a state-of-the-art analysis of the industry from two of its most successful entrepreneurs and a top business school professor, bringing rigor and actionable insight." -- Dr Richard Mason, CEO of Apollo Therapeutics and former head of Johnson & Johnson's London Innovation Center "How is it possible that a few thousand small companies, many of them short-lived, can out-compete the mighty pharma majors at their own game? Understanding this puzzle is of fundamental importance for industry leaders and policy makers alike. This marvelous insider analysis is a must-read." -- Stefan Scholtes, Dennis Gillings Professor of Health Management, Cambridge University Centre for Health Leadership & Enterprise "A remarkable synthesis and analysis of the Biotech industry that is a must-read for those trying to develop new life-saving medicines." -- Margaret A. Liu, M.D., DSchc, MDhc, FISV, CEO of Pax Therapeutics, and board member, Ipsen, S.A. "Anyone who wants to understand how to leverage ecosystems for innovation in the face of uncertainty must read this rigorous analysis of how biotech companies, investors, government and big pharma have worked together to achieve some of the biggest scientific and commercial breakthroughs of the last century." -- Arnoud De Meyer, Professor Emeritus and former President, Singapore Management University "A must read for everybody interested in the medical biotech industry, practically relevant and theoretically sound." -- Jürgen Mihm, , Professor of Technology and Operations Management at INSEAD "An outstanding overview of the science and the business of innovative drugs. Students, researchers and policy makers will be immensely benefited from this book." -- Mahmud Hassan, Ph.D, Professor and Director, Pharmaceutical Management Program, Rutgers Business School, "Written with authority" -- Financial Times"A fascinating guide to the complex business of biotechnology, with deep insights into the key factors, players, interactions and behaviors that have shaped the success of this industry. Suitable as a primer for those with no knowledge of the field, or as a refresher for the cognoscenti. Trigger warning: contains material that may distress pharma management" -- Sir Gregory Winter FRS, Trinity College, Cambridge University, recipient of 2018 Nobel Prize in Chemistry"A must read for all biotechnology leaders, this is a state-of-the-art analysis of the industry from two of its most successful entrepreneurs and a top business school professor, bringing rigor and actionable insight." -- Dr Richard Mason, CEO of Apollo Therapeutics and former head of Johnson & Johnson's London Innovation Center"How is it possible that a few thousand small companies, many of them short-lived, can out-compete the mighty pharma majors at their own game? Understanding this puzzle is of fundamental importance for industry leaders and policy makers alike. This marvelous insider analysis is a must-read." -- Stefan Scholtes, Dennis Gillings Professor of Health Management, Cambridge University Centre for Health Leadership & Enterprise"A remarkable synthesis and analysis of the Biotech industry that is a must-read for those trying to develop new life-saving medicines." -- Margaret A. Liu, M.D., DSchc, MDhc, FISV, CEO of Pax Therapeutics, and board member, Ipsen, S.A."Anyone who wants to understand how to leverage ecosystems for innovation in the face of uncertainty must read this rigorous analysis of how biotech companies, investors, government and big pharma have worked together to achieve some of the biggest scientific and commercial breakthroughs of the last century." -- Arnoud De Meyer, Professor Emeritus and former President, Singapore Management University"A must read for everybody interested in the medical biotech industry, practically relevant and theoretically sound." -- Jürgen Mihm, , Professor of Technology and Operations Management at INSEAD"An outstanding overview of the science and the business of innovative drugs. Students, researchers and policy makers will be immensely benefited from this book." -- Mahmud Hassan, Ph.D, Professor and Director, Pharmaceutical Management Program, Rutgers Business School, "Written with authority" -- Financial Times"A fascinating guide to the complex business of biotechnology, with deep insights into the key factors, players, interactions and behaviors that have shaped the success of this industry. Suitable as a primer for those with no knowledge of the field, or as a refresher for the cognoscenti. Trigger warning: contains material that may distress pharma management" -- Sir Gregory Winter FRS, Trinity College, Cambridge University, recipient of 2018 Nobel Prize inChemistry"A must read for all biotechnology leaders, this is a state-of-the-art analysis of the industry from two of its most successful entrepreneurs and a top business school professor, bringing rigor and actionable insight." -- Dr Richard Mason, CEO of Apollo Therapeutics and former head of Johnson & Johnson's London Innovation Center"How is it possible that a few thousand small companies, many of them short-lived, can out-compete the mighty pharma majors at their own game? Understanding this puzzle is of fundamental importance for industry leaders and policy makers alike. This marvelous insider analysis is a must-read." -- Stefan Scholtes, Dennis Gillings Professor of Health Management, Cambridge University Centre for Health Leadership & Enterprise"A remarkable synthesis and analysis of the Biotech industry that is a must-read for those trying to develop new life-saving medicines." -- Margaret A. Liu, M.D., DSchc, MDhc, FISV, CEO of Pax Therapeutics, and board member, Ipsen, S.A."Anyone who wants to understand how to leverage ecosystems for innovation in the face of uncertainty must read this rigorous analysis of how biotech companies, investors, government and big pharma have worked together to achieve some of the biggest scientific and commercial breakthroughs of the last century." -- Arnoud De Meyer, Professor Emeritus and former President, Singapore Management University"A must read for everybody interested in the medical biotech industry, practically relevant and theoretically sound." -- Jürgen Mihm, , Professor of Technology and Operations Management at INSEAD"An outstanding overview of the science and the business of innovative drugs. Students, researchers and policy makers will be immensely benefited from this book." -- Mahmud Hassan, Ph.D, Professor and Director, Pharmaceutical Management Program, Rutgers Business School
Publication Name
From Breakthrough to Blockbuster : the Business of Biotechnology
Table of Content
List of Figures and Tables Preface Chapter 1: Following the Map of the Genome Chapter 2: The Molecules Chapter 3: The Costly Drug Development Process Chapter 4: The Companies Chapter 5: Biotech-Pharma Alliances Chapter 6: The Biotech Entrepreneur Chapter 7: The Biotech Industry Track Record Chapter 8: The Future of the Biotech Industry Appendix 1 Appendix 2 Bibliography Index About the Authors
Lccn
2021-038556
Dewey Decimal
338.4/76606
Intended Audience
Trade
Dewey Edition
23/Eng/20211004
Illustrated
Yes
Item description from the seller
Business seller information
Value Added Tax Number:
- GB 864 1548 11
Seller assumes all responsibility for this listing.
eBay item number:305352815024
Shipping and handling
Item does not ship to United States
Item location:
GU14 0GT, United Kingdom
Ships to:
Albania, Algeria, American Samoa, Americas, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Aruba, Asia, Azerbaijan Republic, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, British Virgin Islands, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde Islands, Cayman Islands, Central African Republic, Chad, Chile, China, Colombia, Comoros, Cook Islands, Costa Rica, Cyprus, Czech Republic, Côte d'Ivoire (Ivory Coast), Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Estonia, Ethiopia, Europe, Falkland Islands (Islas Malvinas), Fiji, Finland, French Guiana, French Polynesia, Gabon Republic, Gambia, Georgia, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guernsey, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iraq, Israel, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mauritius, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Namibia, Nepal, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Republic of Croatia, Republic of the Congo, Reunion, Romania, Rwanda, Saint Helena, Saint Kitts-Nevis, Saint Lucia, Saint Pierre and Miquelon, Saint Vincent and the Grenadines, San Marino, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, South Africa, South Korea, Sri Lanka, Suriname, Svalbard and Jan Mayen, Swaziland, Sweden, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Turks and Caicos Islands, Tuvalu, Uganda, United Arab Emirates, Uruguay, Uzbekistan, Vanuatu, Vatican City State, Venezuela, Vietnam, Virgin Islands (U.S.), Wallis and Futuna, Western Sahara, Western Samoa, Zambia, Zimbabwe
Excludes:
Afghanistan, Australia, Austria, Belarus, France, Germany, Ireland, Italy, Libya, Nauru, Netherlands, Russian Federation, Somalia, Spain, Switzerland, Ukraine, United Kingdom, United States, Yemen
| Handling time |
|---|
| Will usually ship within 2 business days of receiving cleared payment. |
| Taxes |
|---|
| Taxes may be applicable at checkout. Learn moreLearn more about paying tax on eBay purchases |
Sales tax for an item #305352815024
Sales tax for an item #305352815024
Seller collects sales tax for items shipped to the following provinces:
| Province | Sales Tax Rate |
|---|
Return policy
| After receiving the item, contact seller within |
|---|
| 30 days after the buyer receives it |
The buyer is responsible for return shipping costs.
Payment details
Payment methods
Popular categories from this store
Seller feedback (182,711)
u***n (38)- Feedback left by buyer.
Past 6 months
Verified purchase
Product is 95% alike picture but a little more blurry. Controller play well but had a notice from psn that my joypad wasn't authentic and could by problematic🤷♂️ no trouble so far! Shipping was fast but no tracking and worst packaging ever.. like the box came banged up... send a question to seller never had a reply 😅.... Good product overall, excellent price, fast shipping, wrapped only on 4 sides out of 6, no tracking and never reply... 4★ product / 2★ seller ✌️
l***t (120)- Feedback left by buyer.
Past 6 months
Verified purchase
The book is in perfect condition, brand new, and is exactly as described. This item is difficult to find here, and the seller priced it very reasonably. It shipped from the UK to Canada, and unfortunately took a little longer to arrive than the seller hoped, but it was shipped less than 24 hours after I purchased. When I contacted the seller, they were very responsive and helpful. I would not hesitate to purchase from this seller again. Definitely recommend!
s***a (696)- Feedback left by buyer.
Past month
Verified purchase
AAA seller. Item came as described and within the due date. Great communication. Well packed and no damage to the case.
Product ratings and reviews
More to explore:
- Lisa Scottoline Audiobooks,
- Fiction Books & Lisa Jackson Fiction,
- Fiction Books & Lisa Kleypas Fiction,
- Fiction Books & Lisa Gardner Fiction,
- Lisa Frank Book Covers,
- Fiction Books & Lisa Scottoline Fiction,
- Lisa Kleypas Fiction Romance Fiction & Books,
- Lisa Gardner Fiction Thriller Fiction & Books,
- Lisa Jackson Fiction & Books in English Nonfiction,
- Lisa Kleypas Fiction & Books in English Fiction